Effect of pomegranate seed oil on obese type 2 diabetic patients - Trial IRCT20100606004105N15
Access comprehensive clinical trial information for IRCT20100606004105N15 through Pure Global AI's free database. This phase not specified trial is sponsored by Tabriz University of Medical Sciences and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20100606004105N15
Completed
biological
Trial Details
Iranian Registry Of Clinical Trial โข IRCT20100606004105N15
Effect of pomegranate seed oil on obese type 2 diabetic patients
The effects of pomegranate seed oil supplementation on the PPAR gamma and GLUT4 genes expression and the serum levels of IL-6, TNF-ฮฑ and hs-CRP inflammatory factors and Glycemic indexes in obese type 2 diabetic patients: randomized controlled clinical tri
Study Focus
Sponsor & Location
Tabriz University of Medical Sciences
Iran
Timeline & Enrollment
N/A
Dec 22, 2017
N/A
ICD-10 Classifications
Other specified diabetes mellitus without complications
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus
Other specified diabetes mellitus with other specified complications
Other specified diabetes mellitus with unspecified complications
Data Source
Iranian Registry Of Clinical Trial
IRCT20100606004105N15
Non-Device Trial